Skip to main content
Beginner 3 min read

What Does an NTRK Fusion Mean?

NTRK fusion explained for patients: what it is, why it may affect treatment options, and what to ask about testing.

NCI source:National Cancer Institute — Tumor-agnostic cancer therapies (PDQ)

Review status: AI-assisted, editorial review complete. Not reviewed by a clinician. How we check pages

The short answer

An NTRK fusion is a biomarker result. It means a gene fusion involving an NTRK gene. In some cancers, biomarker results can help guide targeted therapy, immunotherapy, or clinical trial options, but the result only matters in context.

  • An NTRK fusion is a biomarker or molecular result, not a treatment decision by itself.

  • It can be relevant in rare subsets of many solid tumors.

  • A positive result may or may not change treatment depending on cancer type, stage, prior treatment, and available options.

  • Ask whether the result is from tumor testing, blood testing, inherited genetic testing, or another method.

Choose how you want to read this

The whole article, with every detail and caution.

The short answer

An NTRK fusion means part of an NTRK gene has broken off and joined a different gene. NTRK fusions are rare. They can occur in many different solid tumors, in adults and in children.

Where it may be relevant

This result can matter in a small share of many kinds of solid tumors. Not everyone with these cancers needs, or benefits from, the same testing or treatment.

Why it can affect treatment options

NCI lists three FDA-approved drugs that target NTRK fusions in solid tumors: larotrectinib, entrectinib, and repotrectinib. They are chosen by the biomarker, not by where the cancer started. Your team decides whether one fits your situation. Across three trials, tumors shrank or cleared in 75% of 55 people treated with larotrectinib. Across three trials in adults, entrectinib did the same in 57% of 54 adults; in children, it worked in 70% of 33 people. Repotrectinib, the newest of the three, shrank or cleared tumors in 58% of 40 people who had not had a prior TRK inhibitor, and in 50% of 48 who had.

What this result does NOT tell you

A strong response rate in trials does not guarantee your cancer will respond, or respond for as long as someone else's did. Ask your team what happens if a drug stops working. NCI notes repotrectinib was active in people who had already had a TRK inhibitor. This result also does not tell you which cancer type you have. NTRK fusions occur in many different cancers, so the fusion itself, not the original tumor type, guides treatment here.

Is this urgent?

An NTRK fusion result is not itself an emergency. But it can open a treatment option, so ask your team how soon to act once it is confirmed. Call your team right away about any new or worsening symptoms.

Questions to ask

  • Has the fusion been confirmed, and by which type of test?
  • Which TRK inhibitor fits my situation and treatment history?
  • What does monitoring look like while I am on the drug?
  • What is the plan if the drug stops working?
  • Is a clinical trial relevant, given how much research is still ongoing in this area?

Sources

A woman in headscarf stands in a clinic hallway near an MRI machine

Common questions

What is an NTRK fusion?

An NTRK fusion means a gene fusion involving an NTRK gene. It is one type of result that may appear on a biomarker, molecular, genomic, or pathology report.

Can it affect treatment?

Sometimes. Certain biomarkers can point toward targeted therapy, immunotherapy, or a clinical trial, but the same result can mean different things in different cancers.

What should I ask my oncologist?

Ask whether the result is actionable for your cancer, whether a matched treatment exists, and whether a trial is relevant.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

More words from this kind of report

Other guides in biomarker & genetic tests.

Your next step

Look up more plain-language explanations for report wording.

Decode another report term
Talk to a person

Talk with a trained specialist or navigator

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.

Prepared by Cancer Explained's AI-assisted editorial system

Written from National Cancer Institute material and compared with the source cited below.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Sources last checked: 2026-10-02 what this meansLast updated: 2026-08-18Next planned review: 2027-07-30

Review details and limits

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

More on this topic

Words to know

Tap any term to see what it means.

Browse the full glossary →

Knowledge check

0 of 3 answered

  1. Q1.NTRK fusion is best understood as...
  2. Q2.What can biomarker testing sometimes help select?
  3. Q3.What is a useful question about a biomarker result?

This self-assessment checks understanding of educational content only. It is not medical advice.

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Editorial review complete — This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.